<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00754338</url>
  </required_header>
  <id_info>
    <org_study_id>P/279/07/L</org_study_id>
    <nct_id>NCT00754338</nct_id>
  </id_info>
  <brief_title>Evaluation of Disinfecting Solutions and Protein Remover With a Silicone Hydrogel Lens</brief_title>
  <official_title>Evaluation of Disinfecting Solutions and Protein Remover With a Silicone Hydrogel Lens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Waterloo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Waterloo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if reduced lens deposits and increased comfort can
      be achieved by using Multipurpose disinfecting solutions (MPDS) in a no-rub format but in
      conjunction with an intensive cleaner, rather than using MPDS in a rub format.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to determine if reduced lens deposits and increased comfort can
      be achieved by using Multipurpose disinfecting solutions (MPDS) in a no-rub format but in
      conjunction with an intensive cleaner, rather than using MPDS in a rub format by observing
      changes within the cornea and collecting subjective ratings.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">September 2008</completion_date>
  <primary_completion_date type="Actual">July 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comfort</measure>
    <time_frame>4 weeks</time_frame>
    <description>Subjective comfort ratings on analog scale (0= very poor comfort; 100= excellent comfort), self report by subject based on single criterion 'comfort'.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lens Wettability</measure>
    <time_frame>4 weeks</time_frame>
    <description>Subjective grading of contact lens surface wettability by investigator (0=excellent; 4=severely reduced).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lens Deposits</measure>
    <time_frame>4 weeks</time_frame>
    <description>Subjective grading of contact lens surface deposits by investigator (0=no deposits; 4=severe deposits).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Dryness</measure>
    <time_frame>4 weeks</time_frame>
    <description>Subjective dryness ratings on analog scale (0= very dry; 100= not dry at all), self report by subject based on single criterion 'dryness'.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective Vision</measure>
    <time_frame>4 weeks</time_frame>
    <description>Subjective vision ratings on analog scale (0= poor vision; 100= excellent vision), self report by subject based on single criterion 'vision'.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Corneal Staining</measure>
    <time_frame>4 weeks</time_frame>
    <description>Grading based on Type (0=None; 100=patch)and extent of staining (0=None; 100= Entire corneal region). Final value is Type multiplied by Extent.
Corneal staining is a test that uses an orange dye (fluorescein) and a blue light to detect damage to the cornea (front surface of eye) from minor abrasions.
A strip of blotting paper containing the dye was touched to the eyelid margin. Upon blinking, the dye spreads and coats the front surface of the eye along with the tear film covering the surface of the cornea. The investigator then rated the size, location and shape of the staining.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">76</enrollment>
  <condition>Ametropia</condition>
  <arm_group>
    <arm_group_label>Phase1 - Arm 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Phase1 - Arm 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Phase 2 - Arm 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Phase 2 - Arm 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Alcon Opti-Free® RepleniSH® with Supraclens®</intervention_name>
    <description>Marketed Multipurpose Disinfecting Care System + Marketed contact lens protein remover</description>
    <arm_group_label>Phase1 - Arm 1</arm_group_label>
    <arm_group_label>Phase1 - Arm 2</arm_group_label>
    <arm_group_label>Phase 2 - Arm 1</arm_group_label>
    <arm_group_label>Phase 2 - Arm 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Alcon Opti-Free® RepleniSH®</intervention_name>
    <description>Marketed Multipurpose Disinfecting Care System</description>
    <arm_group_label>Phase1 - Arm 1</arm_group_label>
    <arm_group_label>Phase1 - Arm 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>B&amp;L ReNu MultiPlus™</intervention_name>
    <description>Marketed Multipurpose Disinfecting Care Systems</description>
    <arm_group_label>Phase 2 - Arm 1</arm_group_label>
    <arm_group_label>Phase 2 - Arm 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Is at least 17 years of age and has full legal capacity to volunteer.

          -  Has read, understood and signed an information consent letter.

          -  Is willing and able to follow instructions and maintain the appointment schedule.

          -  Is correctable to a visual acuity of 6/9 or better (in each eye) with their habitual
             vision correction.

          -  Has clear corneas and no active ocular disease.

          -  Has had an ocular examination in the last two years.

          -  Is a current soft lens wearer, replacing their lenses every two weeks to one month.

          -  Has a distance contact lens prescription between +6.00D to -10.00 DS and can be
             successfully fit with the study lens.

          -  Has astigmatism less than or equal to -1.00 DC.

        Exclusion Criteria:

          -  Has any signs or symptoms of dry eye.

          -  Has any clinically significant blepharitis.

          -  Has undergone corneal refractive surgery.

          -  Is aphakic.

          -  Has any active ocular disease.

          -  Has any systemic disease affecting ocular health.

          -  Is using any systemic or topical medications that may affect ocular health.

          -  Has known sensitivity to the diagnostic pharmaceuticals to be used in the study.

          -  Is pregnant or lactating.

          -  Is participating in any other type of clinical or research study.

          -  Currently wears daily disposable lenses.

          -  Currently wears lenses on an extended wear basis.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>17 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Desmond Fonn, MOptom</last_name>
    <role>Study Chair</role>
    <affiliation>University of Waterloo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre for Contact Lens Research, School of Optometry, University of Waterloo.</name>
      <address>
        <city>Waterloo</city>
        <state>Ontario</state>
        <zip>N2L3G1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 17, 2008</study_first_submitted>
  <study_first_submitted_qc>September 17, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 18, 2008</study_first_posted>
  <results_first_submitted>March 26, 2010</results_first_submitted>
  <results_first_submitted_qc>August 23, 2010</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 20, 2010</results_first_posted>
  <last_update_submitted>September 28, 2010</last_update_submitted>
  <last_update_submitted_qc>September 28, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 5, 2010</last_update_posted>
  <responsible_party>
    <name_title>Desmond Fonn, MOptom.</name_title>
    <organization>Centre for Contact Lens Research</organization>
  </responsible_party>
  <keyword>comfort</keyword>
  <keyword>wetability</keyword>
  <keyword>protein deposit</keyword>
  <keyword>lipid deposit</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Refractive Errors</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dipivefrin</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment started January 2008 at CCLR (Study completed July 2008)</recruitment_details>
      <pre_assignment_details>Phase 1 - 38 participants enrolled, Phase 2 - 38 participants enrolled. For both Phase 1 and 2 a washout period of at least one day, during which time participants wore spectacles and no contact lenses.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Ph1: 1st-RepleniSH(No-rub) &amp; Supraclens, 2nd RepleniSH(Rub)</title>
          <description>Phase 1 - Alcon RepleniSH™ (Contact lens cleaning and disinfecting solution) with 'no lens rub' and Supraclens® (Daily protein remover) first, and Alcon RepleniSH™ 'with lens rub' second. Participants wore PureVision lenses on a daily wear basis for at least eight to ten hours per day and at least six days per week for the duration of the study.</description>
        </group>
        <group group_id="P2">
          <title>Ph1: 1st-RepleniSH(Rub), 2nd-RepleniSH(No-rub) &amp; Supraclens</title>
          <description>Phase 1 - Alcon RepleniSH™ (Contact lens cleaning and disinfecting solution) 'with lens rub' first, and Alcon RepleniSH™ with 'no lens rub' and Supraclens® (Daily protein remover) second. Participants wore PureVision lenses on a daily wear basis for at least eight to ten hours per day and at least six days per week for the duration of the study.</description>
        </group>
        <group group_id="P3">
          <title>Ph2: 1st-RepleniSH(No-rub)&amp;Supraclens, 2nd ReNUMultiplus(Rub)</title>
          <description>Phase 2 - Alcon RepleniSH™ (Contact lens cleaning and disinfecting solution) with 'no lens rub' and Supraclens® (Daily protein remover) first, and B&amp;L ReNu MultiPlus™ (Contact lens cleaning and disinfecting solution) 'with lens rub' second. Participants wore PureVision lenses on a daily wear basis for at least eight to ten hours per day and at least six days per week for the duration of the study.</description>
        </group>
        <group group_id="P4">
          <title>Ph2: 1st-ReNu Multiplus(Rub), 2nd RepleniSH(No-rub)&amp;Supraclens</title>
          <description>Phase 2 - B&amp;L ReNu MultiPlus™ (Contact lens cleaning and disinfecting solution) 'with lens rub' first, and Alcon RepleniSH™ (Contact lens cleaning and disinfecting solution) with 'no lens rub' and Supraclens® (Daily protein remover) second. Participants wore PureVision lenses on a daily wear basis for at least eight to ten hours per day and at least six days per week for the duration of the study.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>First Intervention for Phase1&amp;Phase2</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="21"/>
                <participants group_id="P3" count="19"/>
                <participants group_id="P4" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="18"/>
                <participants group_id="P3" count="16"/>
                <participants group_id="P4" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Second Intervention for Phase1&amp;Phase2</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="18"/>
                <participants group_id="P3" count="16"/>
                <participants group_id="P4" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="17"/>
                <participants group_id="P3" count="16"/>
                <participants group_id="P4" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Ph1: RepleniSH(No-rub) &amp; Supraclens</title>
          <description>Phase 1 - Alcon RepleniSH™ (Contact lens cleaning and disinfecting solution) with 'no lens rub' and Supraclens® (Daily protein remover) group.</description>
        </group>
        <group group_id="B2">
          <title>Ph1: RepleniSH(Rub)</title>
          <description>Phase 1 - Alcon RepleniSH™ (Contact lens cleaning and disinfecting solution) 'with lens rub' group.</description>
        </group>
        <group group_id="B3">
          <title>Ph2: RepleniSH(No-rub) &amp; Supraclens</title>
          <description>Phase 2 - Alcon RepleniSH™ (Contact lens cleaning and disinfecting solution) with 'no lens rub' and Supraclens® (Daily protein remover) group.</description>
        </group>
        <group group_id="B4">
          <title>Ph2: ReNu Multiplus(Rub)</title>
          <description>Phase 2 - B&amp;L ReNu MultiPlus™ (Contact lens cleaning and disinfecting solution) 'with lens rub' group.</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="17"/>
            <count group_id="B2" value="21"/>
            <count group_id="B3" value="19"/>
            <count group_id="B4" value="19"/>
            <count group_id="B5" value="76"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="19"/>
                    <measurement group_id="B4" value="19"/>
                    <measurement group_id="B5" value="76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28" spread="11"/>
                    <measurement group_id="B2" value="21" spread="3"/>
                    <measurement group_id="B3" value="30" spread="9"/>
                    <measurement group_id="B4" value="24" spread="7"/>
                    <measurement group_id="B5" value="26" spread="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="17"/>
                    <measurement group_id="B4" value="14"/>
                    <measurement group_id="B5" value="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="5"/>
                    <measurement group_id="B5" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="19"/>
                    <measurement group_id="B4" value="19"/>
                    <measurement group_id="B5" value="76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Comfort</title>
        <description>Subjective comfort ratings on analog scale (0= very poor comfort; 100= excellent comfort), self report by subject based on single criterion 'comfort'.</description>
        <time_frame>4 weeks</time_frame>
        <population>analysis was per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>Ph1: RepleniSH(No-rub) &amp; Supraclens</title>
            <description>Phase 1 - Comfort data for Alcon RepleniSH™ (Contact lens cleaning and disinfecting solution) with 'no lens rub' and Supraclens® (Daily protein remover) group.</description>
          </group>
          <group group_id="O2">
            <title>Ph1: RepleniSH(Rub)</title>
            <description>Phase 1 - Comfort data for Alcon RepleniSH™ (Contact lens cleaning and disinfecting solution) 'with lens rub' group</description>
          </group>
          <group group_id="O3">
            <title>Ph2: RepleniSH(No-rub) &amp; Supraclens</title>
            <description>Phase 2 - Alcon RepleniSH™ (Contact lens cleaning and disinfecting solution) with 'no lens rub' and Supraclens® (Daily protein remover) group.</description>
          </group>
          <group group_id="O4">
            <title>Ph2: ReNu Multiplus(Rub)</title>
            <description>Phase 2 - B&amp;L ReNu MultiPlus™ (Contact lens cleaning and disinfecting solution) 'with lens rub' group.</description>
          </group>
        </group_list>
        <measure>
          <title>Comfort</title>
          <description>Subjective comfort ratings on analog scale (0= very poor comfort; 100= excellent comfort), self report by subject based on single criterion 'comfort'.</description>
          <population>analysis was per protocol</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="34"/>
                <count group_id="O3" value="34"/>
                <count group_id="O4" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86" spread="13"/>
                    <measurement group_id="O2" value="86" spread="15"/>
                    <measurement group_id="O3" value="87" spread="14"/>
                    <measurement group_id="O4" value="86" spread="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Dryness</title>
        <description>Subjective dryness ratings on analog scale (0= very dry; 100= not dry at all), self report by subject based on single criterion 'dryness'.</description>
        <time_frame>4 weeks</time_frame>
        <population>analysis was per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>Ph1: RepleniSH(No-rub) &amp; Supraclens</title>
            <description>Phase 1 - Alcon RepleniSH™ (Contact lens cleaning and disinfecting solution) with 'no lens rub' and Supraclens® (Daily protein remover) group.</description>
          </group>
          <group group_id="O2">
            <title>Ph1: RepleniSH(Rub)</title>
            <description>Phase 1 - Alcon RepleniSH™ (Contact lens cleaning and disinfecting solution) 'with lens rub' group.</description>
          </group>
          <group group_id="O3">
            <title>Ph2: RepleniSH(No-rub) &amp; Supraclens</title>
            <description>Phase 2 - Alcon RepleniSH™ (Contact lens cleaning and disinfecting solution) with 'no lens rub' and Supraclens® (Daily protein remover) group.</description>
          </group>
          <group group_id="O4">
            <title>Ph2: ReNu Multiplus(Rub)</title>
            <description>Phase 2 - B&amp;L ReNu MultiPlus™ (Contact lens cleaning and disinfecting solution) 'with lens rub' group.</description>
          </group>
        </group_list>
        <measure>
          <title>Dryness</title>
          <description>Subjective dryness ratings on analog scale (0= very dry; 100= not dry at all), self report by subject based on single criterion 'dryness'.</description>
          <population>analysis was per protocol</population>
          <units>Units on a Scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="34"/>
                <count group_id="O3" value="34"/>
                <count group_id="O4" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85" spread="14"/>
                    <measurement group_id="O2" value="86" spread="16"/>
                    <measurement group_id="O3" value="85" spread="15"/>
                    <measurement group_id="O4" value="85" spread="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subjective Vision</title>
        <description>Subjective vision ratings on analog scale (0= poor vision; 100= excellent vision), self report by subject based on single criterion 'vision'.</description>
        <time_frame>4 weeks</time_frame>
        <population>analysis was per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>Ph1: RepleniSH(No-rub) &amp; Supraclens</title>
            <description>Phase 1 - Alcon RepleniSH™ (Contact lens cleaning and disinfecting solution) with 'no lens rub' and Supraclens® (Daily protein remover) group.</description>
          </group>
          <group group_id="O2">
            <title>Ph1: RepleniSH(Rub)</title>
            <description>Phase 1 - Alcon RepleniSH™ (Contact lens cleaning and disinfecting solution) 'with lens rub' group.</description>
          </group>
          <group group_id="O3">
            <title>Ph2: RepleniSH(No-rub) &amp; Supraclens</title>
            <description>Phase 2 - Alcon RepleniSH™ (Contact lens cleaning and disinfecting solution) with 'no lens rub' and Supraclens® (Daily protein remover) group.</description>
          </group>
          <group group_id="O4">
            <title>Ph2: ReNu Multiplus(Rub)</title>
            <description>Phase 2 - B&amp;L ReNu MultiPlus™ (Contact lens cleaning and disinfecting solution) 'with lens rub' group.</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Vision</title>
          <description>Subjective vision ratings on analog scale (0= poor vision; 100= excellent vision), self report by subject based on single criterion 'vision'.</description>
          <population>analysis was per protocol</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="34"/>
                <count group_id="O3" value="34"/>
                <count group_id="O4" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89" spread="12"/>
                    <measurement group_id="O2" value="89" spread="13"/>
                    <measurement group_id="O3" value="90" spread="11"/>
                    <measurement group_id="O4" value="90" spread="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Corneal Staining</title>
        <description>Grading based on Type (0=None; 100=patch)and extent of staining (0=None; 100= Entire corneal region). Final value is Type multiplied by Extent.
Corneal staining is a test that uses an orange dye (fluorescein) and a blue light to detect damage to the cornea (front surface of eye) from minor abrasions.
A strip of blotting paper containing the dye was touched to the eyelid margin. Upon blinking, the dye spreads and coats the front surface of the eye along with the tear film covering the surface of the cornea. The investigator then rated the size, location and shape of the staining.</description>
        <time_frame>4 weeks</time_frame>
        <population>analysis was per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>Ph1: RepleniSH(No-rub) &amp; Supraclens</title>
            <description>Phase 1 - Alcon RepleniSH™ (Contact lens cleaning and disinfecting solution) with 'no lens rub' and Supraclens® (Daily protein remover) group.</description>
          </group>
          <group group_id="O2">
            <title>Ph1: RepleniSH(Rub)</title>
            <description>Phase 1 - Alcon RepleniSH™ (Contact lens cleaning and disinfecting solution) 'with lens rub' group.</description>
          </group>
          <group group_id="O3">
            <title>Ph2: RepleniSH(No-rub) &amp; Supraclens</title>
            <description>Phase 2 - Alcon RepleniSH™ (Contact lens cleaning and disinfecting solution) with 'no lens rub' and Supraclens® (Daily protein remover) group.</description>
          </group>
          <group group_id="O4">
            <title>Ph2: ReNu Multiplus(Rub)</title>
            <description>Phase 2 - B&amp;L ReNu MultiPlus™ (Contact lens cleaning and disinfecting solution) 'with lens rub' group.</description>
          </group>
        </group_list>
        <measure>
          <title>Corneal Staining</title>
          <description>Grading based on Type (0=None; 100=patch)and extent of staining (0=None; 100= Entire corneal region). Final value is Type multiplied by Extent.
Corneal staining is a test that uses an orange dye (fluorescein) and a blue light to detect damage to the cornea (front surface of eye) from minor abrasions.
A strip of blotting paper containing the dye was touched to the eyelid margin. Upon blinking, the dye spreads and coats the front surface of the eye along with the tear film covering the surface of the cornea. The investigator then rated the size, location and shape of the staining.</description>
          <population>analysis was per protocol</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="34"/>
                <count group_id="O3" value="34"/>
                <count group_id="O4" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47" spread="111"/>
                    <measurement group_id="O2" value="55" spread="113"/>
                    <measurement group_id="O3" value="52" spread="108"/>
                    <measurement group_id="O4" value="322" spread="479"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Lens Wettability</title>
        <description>Subjective grading of contact lens surface wettability by investigator (0=excellent; 4=severely reduced).</description>
        <time_frame>4 weeks</time_frame>
        <population>analysis was per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>Ph1: RepleniSH(No-rub) &amp; Supraclens</title>
            <description>Phase 1 - Alcon RepleniSH™ (Contact lens cleaning and disinfecting solution) with 'no lens rub' and Supraclens® (Daily protein remover) group.</description>
          </group>
          <group group_id="O2">
            <title>Ph1: RepleniSH(Rub)</title>
            <description>Phase 1 - Alcon RepleniSH™ (Contact lens cleaning and disinfecting solution) 'with lens rub' group.</description>
          </group>
          <group group_id="O3">
            <title>Ph2: RepleniSH(No-rub) &amp; Supraclens</title>
            <description>Phase 2 - Alcon RepleniSH™ (Contact lens cleaning and disinfecting solution) with 'no lens rub' and Supraclens® (Daily protein remover) group.</description>
          </group>
          <group group_id="O4">
            <title>Ph2: ReNu Multiplus(Rub)</title>
            <description>Phase 2 - B&amp;L ReNu MultiPlus™ (Contact lens cleaning and disinfecting solution) 'with lens rub' group.</description>
          </group>
        </group_list>
        <measure>
          <title>Lens Wettability</title>
          <description>Subjective grading of contact lens surface wettability by investigator (0=excellent; 4=severely reduced).</description>
          <population>analysis was per protocol</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="34"/>
                <count group_id="O3" value="34"/>
                <count group_id="O4" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.71" spread="0.49"/>
                    <measurement group_id="O2" value="0.72" spread="0.38"/>
                    <measurement group_id="O3" value="0.92" spread="0.68"/>
                    <measurement group_id="O4" value="1.21" spread="0.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Lens Deposits</title>
        <description>Subjective grading of contact lens surface deposits by investigator (0=no deposits; 4=severe deposits).</description>
        <time_frame>4 weeks</time_frame>
        <population>analysis was per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>Ph1: RepleniSH(No-rub) &amp; Supraclens</title>
            <description>Phase 1 - Alcon RepleniSH™ (Contact lens cleaning and disinfecting solution) with 'no lens rub' and Supraclens® (Daily protein remover) group.</description>
          </group>
          <group group_id="O2">
            <title>Ph1: RepleniSH(Rub)</title>
            <description>Phase 1 - Alcon RepleniSH™ (Contact lens cleaning and disinfecting solution) 'with lens rub' group.</description>
          </group>
          <group group_id="O3">
            <title>Ph2: RepleniSH(No-rub) &amp; Supraclens</title>
            <description>Phase 2 - Alcon RepleniSH™ (Contact lens cleaning and disinfecting solution) with 'no lens rub' and Supraclens® (Daily protein remover) group.</description>
          </group>
          <group group_id="O4">
            <title>Ph2: ReNu Multiplus(Rub)</title>
            <description>Phase 2 - B&amp;L ReNu MultiPlus™ (Contact lens cleaning and disinfecting solution) 'with lens rub' group.</description>
          </group>
        </group_list>
        <measure>
          <title>Lens Deposits</title>
          <description>Subjective grading of contact lens surface deposits by investigator (0=no deposits; 4=severe deposits).</description>
          <population>analysis was per protocol</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="34"/>
                <count group_id="O3" value="34"/>
                <count group_id="O4" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.51" spread="0.34"/>
                    <measurement group_id="O2" value="0.54" spread="0.47"/>
                    <measurement group_id="O3" value="0.62" spread="0.43"/>
                    <measurement group_id="O4" value="0.93" spread="0.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>One business day to Office of Research Ethics</time_frame>
      <desc>No adverse events were reported for this study.</desc>
      <group_list>
        <group group_id="E1">
          <title>Ph1: RepleniSH(No-rub) &amp; Supraclens</title>
          <description>Phase 1 - Alcon RepleniSH™ (Contact lens cleaning and disinfecting solution) with 'no lens rub' and Supraclens® (Daily protein remover) group.</description>
        </group>
        <group group_id="E2">
          <title>Ph1: RepleniSH(Rub)</title>
          <description>Phase 1 - Alcon RepleniSH™ (Contact lens cleaning and disinfecting solution) 'with lens rub' group.</description>
        </group>
        <group group_id="E3">
          <title>Ph2: RepleniSH(No-rub) &amp; Supraclens</title>
          <description>Phase 2 - Alcon RepleniSH™ (Contact lens cleaning and disinfecting solution) with 'no lens rub' and Supraclens® (Daily protein remover) group.</description>
        </group>
        <group group_id="E4">
          <title>Ph2: ReNu Multiplus(Rub)</title>
          <description>Phase 2 - B&amp;L ReNu MultiPlus™ (Contact lens cleaning and disinfecting solution) 'with lens rub' group.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Craig A Woods, Research Manager</name_or_title>
      <organization>Centre for Contact Lens Research</organization>
      <phone>1 519 888 4567 ext 36547</phone>
      <email>cawoods@sciborg.uwaterloo.ca</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

